Core Alternative Capital Has $6.58 Million Holdings in CME Group Inc. (NASDAQ:CME)

Core Alternative Capital lowered its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 17.5% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 24,817 shares of the financial services provider's stock after selling 5,279 shares during the quarter. CME Group comprises approximately 1.6% of Core Alternative Capital's holdings, making the stock its 21st largest holding. Core Alternative Capital's holdings in CME Group were worth $6,584,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Wayfinding Financial LLC acquired a new stake in CME Group in the first quarter worth $25,000. Golden State Wealth Management LLC raised its stake in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares during the period. Alpine Bank Wealth Management acquired a new stake in CME Group during the 1st quarter worth $32,000. New Age Alpha Advisors LLC raised its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the period. Finally, Knuff & Co LLC acquired a new stake in shares of CME Group during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Stock Performance

Shares of CME Group stock traded up $5.85 during trading on Monday, hitting $282.55. 2,252,300 shares of the stock were exchanged, compared to its average volume of 2,189,580. The stock has a market capitalization of $101.82 billion, a price-to-earnings ratio of 28.43, a price-to-earnings-growth ratio of 3.75 and a beta of 0.44. The company has a fifty day moving average price of $276.40 and a 200-day moving average price of $258.18. CME Group Inc. has a 1-year low of $193.17 and a 1-year high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The business's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.50 earnings per share. As a group, equities analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.77%. CME Group's dividend payout ratio is currently 50.30%.

Insider Transactions at CME Group

In other CME Group news, Director Larry G. Gerdes sold 2,000 shares of the company's stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total value of $528,200.00. Following the transaction, the director directly owned 38,651 shares of the company's stock, valued at $10,207,729.10. This represents a 4.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Derek Sammann sold 4,650 shares of the company's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the transaction, the insider directly owned 8,336 shares in the company, valued at approximately $2,339,164.96. This represents a 35.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,400 shares of company stock valued at $3,680,610. Corporate insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

Several analysts have commented on CME shares. Piper Sandler raised their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Bank of America raised their price objective on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. UBS Group lifted their price target on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a research note on Thursday, April 3rd. Finally, JPMorgan Chase & Co. dropped their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, CME Group presently has an average rating of "Hold" and a consensus target price of $259.87.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.